clinical protocols typically use 250-500 mcg per injection near the site of injury Cycle length: 6-12 weeks, followed by a 4-8 week break before repeating Research status: Evidence is almost entirely from rodent and small animal models, where BPC-157 has consistently improved functional, structural, and biomechanical outcomes across muscle, tendon, ligament, and bone injuries
And the other thing I'll say is that
Safety Considerations and Adverse Effects While GLP-1 receptor agonists offer numerous benefits, clinicians should be mindful of potential adverse effects
For broader questions about how safe these medications are in general, the SELECT trial data, and what the 2024 to 2026 evidence shows on the most-discussed concerns, see our separate guide on whether weight-loss injections are safe
Vial reconstituido con BAC : Conservacin: 28 C estricto